文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全球肿瘤疫苗相关肿瘤微环境研究趋势:综述与文献计量分析。

Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis.

机构信息

Department of Psychiatry, The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.

Department of Psychiatry, Brain Hospital of Hunan Province (The Second People's Hospital of Hunan Province), Changsha, Hunan, China.

出版信息

Front Immunol. 2024 Feb 6;15:1341596. doi: 10.3389/fimmu.2024.1341596. eCollection 2024.


DOI:10.3389/fimmu.2024.1341596
PMID:38380323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10876793/
Abstract

BACKGROUND: Tumor vaccines have become crucial in cancer immunotherapy, but, only a limited number of phase III clinical trials have demonstrated clinical efficacy. The crux of this issue is the inability of tumor vaccines to effectively harmonize the tumor microenvironment with its intricate interplay. One factor that can hinder the effectiveness of vaccines is the natural immunosuppressive element present in the tumor microenvironment. This element can lead to low rates of T-cell response specific to antigens and the development of acquired resistance. Conversely, anticancer vaccines alter the tumor microenvironment in conflicting manners, inducing both immune activation and immunological evasion. Hence, comprehending the correlation between tumor vaccines and the tumor microenvironment would establish a foundation for forthcoming tumor treatment. OBJECTIVE: Our review explores the realm of research pertaining to tumor vaccinations and the tumor microenvironment. Our objective is to investigate the correlation between tumor vaccines and the tumor microenvironment within this domain. We then focus our review on the dominant international paradigms in this research field and visually illustrates the historical progression and emergent patterns observed in the past. METHODS: From January 1, 1999 to February 7, 2023, 1420 articles on the interplay between tumor vaccines and the tumor microenvironment were published, according to The Clarivate Web of Science (WOS) database used in our review. A bibliometric review was designed for this collection and consisted of an evaluation. The evaluation encompassed various discernible attributes, including the year of publication, the journals in which the articles were published, the authors involved, the affiliated institutions, the geographical locations of the institutions, the references cited, and the keywords employed. RESULTS: Between the years 1999 and 2022, publications saw a significant increase, from 3 to 265 annually. With 72 papers published, Frontiers in Immunology had the most manuscripts published. The Cancer Research publication garnered the highest number of citations, amounting to 2874 citations. The United States exerts significant dominance in the subject, with the National Cancer Institute being recognized as a prominent institution in terms of both productivity and influence. Furthermore, Elizabeth M. Jaffee was recognized as the field's most prolific and influential author with 24 publications and 1,756 citations. The co-occurrence cluster analysis was conducted on the top 197 keywords, resulting in the identification of five distinct clusters. The most recent high-frequency keywords, namely immune therapy, dendritic cell, tumor microenvironment, cancer, and vaccine, signify the emerging frontiers in the interaction between tumor vaccines and the tumor microenvironment. CONCLUSION: Our review uncovers insights into contemporary trends, global patterns of collaboration, fundamental knowledge, research areas of high interest, and emerging frontiers in the field of TME-targeted vaccines.

摘要

背景:肿瘤疫苗已成为癌症免疫疗法的关键,但只有少数三期临床试验显示出临床疗效。问题的关键在于肿瘤疫苗无法有效地协调肿瘤微环境及其错综复杂的相互作用。一个可能阻碍疫苗有效性的因素是肿瘤微环境中存在的天然免疫抑制因素。这一因素可能导致针对抗原的 T 细胞反应率低,并产生获得性耐药性。相反,抗癌疫苗以相互冲突的方式改变肿瘤微环境,诱导免疫激活和免疫逃避。因此,了解肿瘤疫苗与肿瘤微环境之间的相关性将为未来的肿瘤治疗奠定基础。

目的:本综述探讨了肿瘤疫苗与肿瘤微环境领域的研究。我们的目标是研究肿瘤疫苗与肿瘤微环境之间的相关性。然后,我们将重点关注该研究领域的主导国际范式,并直观地展示过去的历史进展和新兴模式。

方法:根据我们综述中使用的 Clarivate Web of Science (WOS) 数据库,从 1999 年 1 月 1 日至 2023 年 2 月 7 日,共发表了 1420 篇关于肿瘤疫苗与肿瘤微环境相互作用的文章。对这一集合进行了文献计量学综述,包括评估。评估涵盖了各种可识别的属性,包括出版年份、发表文章的期刊、作者、所属机构、机构的地理位置、参考文献和使用的关键词。

结果:1999 年至 2022 年间,出版物数量显著增加,从每年 3 篇增加到 265 篇。Frontiers in Immunology 发表的论文最多,有 72 篇。Cancer Research 的引用次数最多,为 2874 次。美国在该领域占据显著优势,国家癌症研究所是生产力和影响力方面的知名机构。此外,Elizabeth M. Jaffee 被认为是该领域最有影响力的作者,共发表了 24 篇论文,被引次数为 1756 次。对前 197 个关键词进行共现聚类分析,共分为 5 个不同的簇。最近出现的高频关键词,如免疫疗法、树突状细胞、肿瘤微环境、癌症和疫苗,标志着肿瘤疫苗与肿瘤微环境相互作用的新兴前沿。

结论:本综述揭示了当代趋势、全球合作模式、基础知识、高关注研究领域和 TME 靶向疫苗领域的新兴前沿。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/771d8f8debbb/fimmu-15-1341596-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/fec26212698d/fimmu-15-1341596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/d21d3ea34bfd/fimmu-15-1341596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/5cb0e88b147b/fimmu-15-1341596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/84d3f2d0613d/fimmu-15-1341596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/dff55e156392/fimmu-15-1341596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/eb46fe2ac81d/fimmu-15-1341596-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/1c0047e4092a/fimmu-15-1341596-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/771d8f8debbb/fimmu-15-1341596-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/fec26212698d/fimmu-15-1341596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/d21d3ea34bfd/fimmu-15-1341596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/5cb0e88b147b/fimmu-15-1341596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/84d3f2d0613d/fimmu-15-1341596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/dff55e156392/fimmu-15-1341596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/eb46fe2ac81d/fimmu-15-1341596-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/1c0047e4092a/fimmu-15-1341596-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3668/10876793/771d8f8debbb/fimmu-15-1341596-g008.jpg

相似文献

[1]
Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis.

Front Immunol. 2024

[2]
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.

Front Immunol. 2024

[3]
Bibliometric study of immunotherapy for hepatocellular carcinoma.

Front Immunol. 2023

[4]
A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022.

Cancer Rep (Hoboken). 2024-8

[5]
Bibliometric analysis of dendritic cell-based vaccines over the past 15 years.

Hum Vaccin Immunother. 2024-12-31

[6]
Evolution and global research trends of immunity in diabetic nephropathy: a bibliometric and visual analysis from 2004 to 2023.

Int Urol Nephrol. 2024-10

[7]
Emerging trends and research foci of oncolytic virotherapy for central nervous system tumors: A bibliometric study.

Front Immunol. 2022

[8]
Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020.

J Control Release. 2022-5

[9]
A bibliometric and visual analysis of cancer-associated fibroblasts.

Front Immunol. 2023

[10]
Global research trends and focus on the link between neutrophil extracellular traps and tumor: a bibliometric and visualization analysis from 2006 to 2024.

Front Immunol. 2024

引用本文的文献

[1]
Clinical Translation Challenges and Strategies for Tumour Vaccines Considering Multiple Delivery Routes.

Vaccines (Basel). 2025-4-27

[2]
The global trend of intravenous anesthesia and tumors: a bibliometric and visualized study.

Perioper Med (Lond). 2025-3-17

[3]
Knowledge mapping of ferroptosis in Parkinson's disease: a bibliometric analysis: 2012-2023.

Front Aging Neurosci. 2024-8-30

[4]
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma.

Cancers (Basel). 2024-8-27

[5]
Dendritic cell-related hub genes in head-and-neck squamous cell carcinoma: implications for prognosis and immunotherapy.

Transl Cancer Res. 2024-7-31

[6]
Bibliometric analysis of research trends in the relationship between frailty and neoplasms over the past decade.

Support Care Cancer. 2024-7-23

本文引用的文献

[1]
Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens.

Fundam Res. 2022-3-26

[2]
Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment.

Vaccines (Basel). 2023-9-7

[3]
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy.

Bioact Mater. 2023-9-6

[4]
Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors.

Front Immunol. 2023

[5]
Tumor-associated myeloid cells in cancer immunotherapy.

J Hematol Oncol. 2023-7-6

[6]
Antigen-Capturing Dendritic-Cell-Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal-Therapy-Induced In Situ Vaccination.

Adv Healthc Mater. 2023-9

[7]
Efficiency of Interferon-γ in Activating Dendritic Cells and Its Potential Synergy with Toll-like Receptor Agonists.

Viruses. 2023-5-19

[8]
TGFβ and the Tumor Microenvironment in Colorectal Cancer.

Cells. 2023-4-12

[9]
Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting.

Int Immunopharmacol. 2022-12

[10]
The main battlefield of mRNA vaccine - Tumor immune microenvironment.

Int Immunopharmacol. 2022-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索